9999999997-15-015848.txt : 20151217
9999999997-15-015848.hdr.sgml : 20151217
20151217134854
ACCESSION NUMBER: 9999999997-15-015848
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20151217
DATE AS OF CHANGE: 20151217
20151123
20151217
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151293059
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G
M94E=(#X^+TUE9&EA0F]X6R P(# @-C$R(#2]#4R]$979I8V52
M1T(^/B]486)S+U,O4W1R=6-T4&%R96YT)R=65MOVE@0?H^4_S#2OMA2<'TNOJVJ2BDA*=4F[2:TJM2N5A!,8@EL
MBDTO_WYGQC9@\'&L[:I=L+\S9Z[?S#G JX_P^O6KV^'X"MPW;^#MU1#>3L[/
M7ET+$!(FB_,S 2[^)R!R'5=J"-S0B31,5N=G+CPA\N8A@*>8XHY;X@1'8("86C>@E1+4*D%SH"
MA?B!X]5"/MW9VAI/[(&R1O9 6E?P@%^T=3D9T;.'@ST:^GC*B;RFJ$Y]=(L^
M(O"=( 0?906UD(>=)L-/J-G]>#*F+_R$W\$E:7P%HR^V$-;P'7^]L<,2 L,/
MM_; LV[)J@-/]P9#-'*@#@S(1)H]?K5(
M+ZKA+GQ,2TP;:3"GC[21P)MZ4V1/-J>-5UB
MC@LKAW%*;Q_Q;48"UP3A3]/"+GE@;O2KK>Z_;7],JO@19^+A^FXM=&-*DX8IS1,>S1]]
M!+8U[%J*R^'NCK/ %NK*)K;DBB+&HO]%' $?J2*>I]3A5U.[K'UFAR*A-\P6
M]':9&\L%/:U%;*7XNF&&Z&$2YVO%5/].4&YQ@\^UL12TF
M*9C8XCE,T=842/OU>EF9H]F:TK@LA6TZY^D&[K?+&"15@9X9-J7=?+^YJ:D>
M/20R_\CWTF1-%52-_*!J\"9&IWW?DG(Y::NME.+U1)T4F*#313*G.*:E,1PD
M8-LW=1]@4U+6MPL2N MV'&=P FSPN7"RLL(G]
MFQ7?L_[<6"I:TN366(P.,:&Q/1VC+[>4.QR>;5Z OBBG'713Q\ LE:#2:0AR
MC%A]@NWFCX[I6OLN$6T?*6WC=2U%^^UQ;3!/*S3S&5)D#>1H=Q2F_
MWB4OOTR+:9%D:8[L@>Z<$>RWR4%H4Z3Z*25]=8+]3 %D,OB?]$@JCFVIRDJM
MAB@F0#*):S$VCD^4@#T]JK5W@BV>IP569U+6X@NUI]2>E(@*B!-6[&?XOITN
MDT42YTR>.3(-JMY.-8_9:A5O*I\DTR5D'$0L.1^E3K$#^/S80#8[YD5.P>4P^+J<"XJ)&7L@70%F.:<-,%.KW4I;GC)6E47( 'GQP^SSA#DN'@
MN"F_6;AH]LW&?[]9&O_O6Q>=Z"^\GI3.9T1G>:)Z+#=I*78&+A&WM-E)%
M8D\[BVRYS'XFZ9-]N/=S,F/Q!?PL>7N)5F.?*6 6 SF$D,N8LY,/YJ5GL/L<
M:-%P#NQ,X/95)+N&".N8W+-)LCGD:WK"[J+\G_]I*C[DW^C(DFX";3ODU_X(
M J*A/E+:CI0B"NCPH7SMB%K*Z!<5 GL1D[WC].\?+33?%'@G6&/#EGA(. 8[
MT@3V?$='/;7 EO;=K]0)Z;G.NHE)U2=O1_6EYW8
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M\.0D?"-7J3!PM#)K=QKKCL.LI%^MC%+^ Y/P(Z0-"F5N9'-T7!E+T9O;G0O4W5B='EP92]4'1'4W1A
M=&4O0DTO3F]R;6%L+T-!(#$^/@T*96YD;V)J#0HX(# @;V)J#0H\/"]4>7!E
M+T9O;G0O4W5B='EP92]4%=I9'1H(#(U-C@O1F]N=%=E:6=H
M=" T,# O6$AE:6=H=" R-3 O3&5A9&EN9R T,B]3=&5M5B T,"]&;VYT0D)O
M>%L@+34V." M,C$V(#(P,# @-CDS72 ^/@T*96YD;V)J#0HQ," P(&]B:@T*
M/#PO075T:&]R*'5S*2 O0W)E871O5YQ+/L[.*2HXE%_%JD"LM+P=+GHD7:'C0&HZ5
M!DO PP:LY5CQ(WVLXV) 5Q9O>8I+R[4/!5K6*BEFJO5QVM0
MR[X[KOOK?3BH^T?03Z#F6Z!45T
M295QE#G'GW'^F&$ S' 9E@ ,SR &2; #!=@A@TPPPQ_@IZ;N^N]MF@K2]36$:@A\?PT!)1@)),%*$!U?/D/P$H1B
MA$)"(:&04$@H)!02"@F%A$)"(:%8H5BA6*%8H=B!\@2G[8ZVM^I"6,38JT7<
MAX?Z-=UEZ47P:PCM,)INM=0S?+T%,QJ=A??^/GP GM WS&IC']0L/:[;S5>R
MXM+G^*Z68=VKVU!O0B?MI/ELW[7[I@W+79U6F#I^M4RH^R:VI[SKF[\U-X;L
M3^Q>GF-\45=Q?3SPFH:>MUT(O9SD0[WNXBC_O>/G*+]JZGWF4@-#"XO@_/Z3 0]FX,,<%K"$%0000@0Q
M))#"&C*PL($M[& /.1100@4'J%V&[*G9[5=D ,LN#9H-"F5N9'-TF4@-#@O4F]O=" Q(# @4B]);F9O
M(#$P(# @4B])1%L\,3DT-$$Y,35$,44S-#,T,T$Q1C4P1$9$-34W,T0R1D0^
M/#$Y-#1!.3$U1#%%,S0S-#-!,48U,$1&1#4U-S-$,D9$/ET@+U!R978@-3$X
H,R]84F5F4W1M(#0X-#<^/@T*